Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke

Fabian Essig; Alexander M Kollikowski; Wolfgang Müllges; Guido Stoll; Karl Georg Haeusler; Michael K Schuhmann; Mirko Pham

doi:10.1001/jamaneurol.2021.0065

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke

JAMA Neurol. 2021 May 1;78(5):615-617. doi: 10.1001/jamaneurol.2021.0065.

Authors

Fabian Essig¹, Alexander M Kollikowski², Wolfgang Müllges¹, Guido Stoll¹, Karl Georg Haeusler¹, Michael K Schuhmann¹, Mirko Pham²

Affiliations

¹ Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
² Department of Neuroradiology, University Hospital Würzburg, Würzburg, Germany.

Abstract

This study evaluates concentrations of local cerebral recombinant tissue plasminogen activator during mechanical thrombectomy treatment in acute stroke.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Brain Ischemia / drug therapy*
Female
Fibrinolytic Agents / therapeutic use*
Humans
Male
Recombinant Proteins / therapeutic use
Stroke / drug therapy*
Thrombolytic Therapy / methods
Tissue Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Recombinant Proteins
Tissue Plasminogen Activator